Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine

Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine

Ovarian cancer (OC) has the highest mortality rate of all gynecological malignancies due to the high prevalence of advanced stages of diagnosis and the high rate of recurrence. Furthermore, the heterogeneity of OC tumors contributes to the rapid development of resistance to conventional chemotherapy...

Full description

Bibliographic Details
Main Authors: Giulia Spagnol, Francesca Sensi, Orazio De Tommasi, Matteo Marchetti, Giulio Bonaldo, Livia Xhindoli, Marco Noventa, Marco Agostini, Roberto Tozzi, Carlo Saccardi
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
ovarian cancer
organoids
tumor microenvironment
extracellular matrix
drug screening
Online Access:https://www.mdpi.com/2072-6694/15/7/2059

Internet

https://www.mdpi.com/2072-6694/15/7/2059

Similar Items